Ассоциация полиморфизмов хромосомы 4q25 у больных с фибрилляцией предсердий
Ассоциация полиморфизмов хромосомы 4q25 у больных с фибрилляцией предсердий
Шульман В.А., Никулина С.Ю., Поплавская Е.Е. и др. Ассоциация полиморфизмов хромосомы 4q25 у больных с фибрилляцией предсердий. КардиоСоматика. 2016; 7 (2): 21–23.
________________________________________________
Shulman V.A., Nikulina S.Yu., Poplavskaia E.E. et al. Association of polymorphisms of chromosome 4q25 in patients with atrial fibrillation. Cardiosomatics. 2016; 7 (2): 21–23.
Ассоциация полиморфизмов хромосомы 4q25 у больных с фибрилляцией предсердий
Шульман В.А., Никулина С.Ю., Поплавская Е.Е. и др. Ассоциация полиморфизмов хромосомы 4q25 у больных с фибрилляцией предсердий. КардиоСоматика. 2016; 7 (2): 21–23.
________________________________________________
Shulman V.A., Nikulina S.Yu., Poplavskaia E.E. et al. Association of polymorphisms of chromosome 4q25 in patients with atrial fibrillation. Cardiosomatics. 2016; 7 (2): 21–23.
В статье рассматривается вопрос о генетической детерминированности фибрилляции предсердий. В частности, показано, что редкий аллель Т полиморфизма rs2200733 на хромосоме 4q25 статистически чаще встречается (р=0,029) у больных с фибрилляцией предсердий по сравнению с данными контрольной группы. Обсуждается вопрос о функциональном значении данного полиморфизма в развитии электрической нестабильности миокарда предсердий.
The article deals with the issue of genetic determination of atrial fibrillation. In particular, it is shown that a rare polymorphism rs2200733 T allele on chromosome 4q25 statistically more frequently (p=0,029) in patients with atrial fibrillation compared with the control group data. The question of the functional significance of this polymorphism in the development of electrical instability of the atrial myocardium is also addressed.
1. Диагностика и лечение фибрилляции предсердий. Рекомендации РКО, ВНОА и АССХ. Рос. кардиол. журн. 2013; 4 (Прил. 3). / Diagnostika i lechenie fibrilliatsii predserdii. Rekomendatsii RKO, VNOA i ASSKh. Ros. kardiol. zhurn. 2013; 4 (Pril. 3). [in Russian]
2. Gudbjartsson DF, Arnar DO, Helgadottir A et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448 (7151): 353–7.
3. Ferrán A, Alegret JM, Subirana I et al. Association between rs2200733 and rs7193343 genetic variants and atrial fibrillation in a Spanish population, and meta-analysis of previous studies. Rev Esp Cardiol (Engl Ed) 2014; 67 (10): 822–9.
4. Mohanty S, Santangeli P, Bai R et al. Variant rs2200733 on chromosome 4q25 confers increased risk of atrial fibrillation: evidence from a meta-analysis. J Cardiovasc Electrophysiol 2013; 24 (2): 155–61.
5. Olesen MS, Holst AG, Jabbari J et al. Genetic loci on chromosomes 4q25, 7p31, and 12p12 are associated with onset of lone atrial fibrillation before the age of 40 years. Can J Cardiol 2012; 28 (2): 191–5.
6. Kiliszek M, Franaszczyk M, Kozluk E et al. Association between variants on chromosome 4q25, 16q22 and 1q21 and atrial fibrillation in the Polish population. PLoS One 2011; 6 (7): e21790.
7. Goodloe AH, Herron KJ, Olson TM. Uncovering an intermediate phenotype associated with rs2200733 at 4q25 in lone atrial fibrillation. Am J Cardiol 2011; 107 (12): 1802–5.
8. Lubitz SA, Sinner MF, Lunetta KL et al. Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation 2010; 122 (10): 976–84.
9. Lee KT, Yeh HY, Tung CP et al. Association of RS2200733 but not RS10033464 on 4q25 with atrial fibrillation based on the recessive model in a Taiwanese population. Cardiology 2010; 116 (3): 151–6.
10. Viviani Anselmi C, Novelli V, Roncarati R et al. Association of rs2200733 at 4q25 with atrial flutter/fibrillation diseases in an Italian population. Heart 2008; 94 (11): 1394–6.
11. Shi L, Li C, Wang C et al. Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population. Hum Genet 2009; 126 (6): 843–9.
12. Kirchhof P, Bax J, Blomstrom-Lundquist C et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J 2009; 30 (24): 2969–77.
13. Page SP, Siddiqui MS, Finlay M et al. Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance? J Cardiovasc Electrophysiol 2011; 22 (3): 265–70.
________________________________________________
1. Diagnostika i lechenie fibrilliatsii predserdii. Rekomendatsii RKO, VNOA i ASSKh. Ros. kardiol. zhurn. 2013; 4 (Pril. 3). [in Russian]
2. Gudbjartsson DF, Arnar DO, Helgadottir A et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448 (7151): 353–7.
3. Ferrán A, Alegret JM, Subirana I et al. Association between rs2200733 and rs7193343 genetic variants and atrial fibrillation in a Spanish population, and meta-analysis of previous studies. Rev Esp Cardiol (Engl Ed) 2014; 67 (10): 822–9.
4. Mohanty S, Santangeli P, Bai R et al. Variant rs2200733 on chromosome 4q25 confers increased risk of atrial fibrillation: evidence from a meta-analysis. J Cardiovasc Electrophysiol 2013; 24 (2): 155–61.
5. Olesen MS, Holst AG, Jabbari J et al. Genetic loci on chromosomes 4q25, 7p31, and 12p12 are associated with onset of lone atrial fibrillation before the age of 40 years. Can J Cardiol 2012; 28 (2): 191–5.
6. Kiliszek M, Franaszczyk M, Kozluk E et al. Association between variants on chromosome 4q25, 16q22 and 1q21 and atrial fibrillation in the Polish population. PLoS One 2011; 6 (7): e21790.
7. Goodloe AH, Herron KJ, Olson TM. Uncovering an intermediate phenotype associated with rs2200733 at 4q25 in lone atrial fibrillation. Am J Cardiol 2011; 107 (12): 1802–5.
8. Lubitz SA, Sinner MF, Lunetta KL et al. Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation 2010; 122 (10): 976–84.
9. Lee KT, Yeh HY, Tung CP et al. Association of RS2200733 but not RS10033464 on 4q25 with atrial fibrillation based on the recessive model in a Taiwanese population. Cardiology 2010; 116 (3): 151–6.
10. Viviani Anselmi C, Novelli V, Roncarati R et al. Association of rs2200733 at 4q25 with atrial flutter/fibrillation diseases in an Italian population. Heart 2008; 94 (11): 1394–6.
11. Shi L, Li C, Wang C et al. Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population. Hum Genet 2009; 126 (6): 843–9.
12. Kirchhof P, Bax J, Blomstrom-Lundquist C et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J 2009; 30 (24): 2969–77.
13. Page SP, Siddiqui MS, Finlay M et al. Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance? J Cardiovasc Electrophysiol 2011; 22 (3): 265–70.
1 ГБОУ ВПО Красноярский государственный медицинский университет им. проф. В.Ф.Войно-Ясенецкого Минздрава России. 660022, Россия, Красноярск, ул. Партизана Железняка, д. 1;
2 ФГБНУ НИИ терапии и профилактической медицины. 630089, Россия, Новосибирск, ул. Бориса Богаткова, д. 175/1
*shulman36@mail.ru
1 Prof. V.F.Voino-Yasenetski Krasnoyarsk State Medical University of the Ministry of Health of the Russian Federation. 660022, Russian Federation, Krasnoyarsk, ul. Partizana Zhelezniaka, d. 1;
2 Scientific research institute of therapy and prophylactic medicine. 630089, Russian Federation, Novosibirsk, ul. Borisa Bogatkova, d. 175/1
*shulman36@mail.ru